• Wed 1 Nov
    9:00 AM - 9:55 AM10 on the Park, Time Warner Center, 60 Columbus Circle, NYC
    The Life Sciences Summit is an early stage investor and business development conference that highlights innovation. The objective of the event is to connect emerging biotech companies and academic innovators with the capital and strategic partners they will need to move new discoveries through clinical development. The two-day program features corporate presentations by promising young companies with transformative science that targets unmet medical needs. It also features informative plenary sessions, business workshops, and therapeutic sessions.

    For more information, visit http://lifesciencessummit.org/



Past Engagements


  • Tue 9 May
    Thu 11 May
    11:00AM-12:15PMWillard InterContinental Hotel, Washington, DC

    Join us in the nation's capital for the 2017 Spring Meeting. This premier IP & Licensing Executives’ meeting will be held May 9-11 at the Willard Intercontinental Hotel, Washington, DC.

    Pre-meeting Education including “Best Practices in Licensing”, will be held May 8-9th along with many other Educational offerings.

    Learn more here.

  • Tue 2 May
    9:10 AMCourtyard Marriott San Diego at Liberty Station

    2017 marks the 5th year for 10x, the annual in-person reunion for the Medical Devices Group, the world's largest medical device community.

    We limit participation to 250 guests to keep it intimate and meaningful. You'll meet people with the skills and services you need to grow your business.  Read More...

  • Fri 28 Apr
    10:30 AMFairleigh Dickinson University

    The symposium will have podium research presentations and a poster session.  The goal is to provide a local platform and promote research done by FDU students and faculty.

  • Sun 23 Apr
    Morning SessionStanford University

    Medicine X is Stanford's premier program on emerging technology and medicine, focusing on patient-centered innovation.

    To view a clip from the 2017 Stanford Medicine X Ed Conference, click here.

  • Wed 19 Apr
    Late MorningDMD, One Boston Place, 37th Floor, Boston, MA 02108

    Springboard Enterprises: Regulatory Pathway Roundtable

  • Fri 7 Apr
    1:15-3:15pmHarvard Business School, Boston, MA

    Will discuss the major future opportunities and challenges for entrepreneurs in health care.

  • Wed 29 Mar
    4:00-7:00pmColumbia University Medical Center, New York

    This course includes clinical and engineering Faculty members, post-docs, research scientists, and graduate students (engineering and MBA).  The goal of the course is to help teams of Faculty and students bring their technologies from the lab to impact patients.

  • Thu 23 Mar
    12:50 PM731 Lexington Avenue, New York, NY

    A gathering of prominent thought leaders discuss the key issues impacting the pharmaceutical, biotech, device, and healthcare services industries in 2016.

    The panel-format event includes key opinion leaders in drug development, healthcare legal and policy experts, and stakeholders in the healthcare industries. Panels will be moderated by Bloomberg Intelligence analysts and will include the opportunity for a discussion with the audience.

    To view the full presentation, visit https://youtu.be/EEPcEzbubtU

  • Thu 23 Mar
    8:30am – 4:30pmBloomberg Global Headquarters, 731 Lexington Avenue New York, NY 10022

    Lunch Keynote Address: Fixing the Broken Drug Development and Approval Model
    Joseph V. Gulfo, MD, MBA, Executive Director of the Lewis Center for Healthcare Innovation and Technology at Fairleigh Dickinson University's School of Pharmacy

  • Wed 11 Jan
    1:00-1:55 PMParc 55 San Francisco, Level 4, Cyril Magnin Ballroom I

    Finding the funding to take an emerging technology to an attractive, fundable company is a challenge in today’s environment. This panel will not only cover key considerations for early-stage medtech companies, but also how the investment landscape has evolved,  and specific strategies for early-stage medtech companies to employ when seeking investment.

    Learn more about this conference.

  • Tue 10 Jan
    2:00-3:00 PMContinental Room 2, Hilton San Francisco Union Square

    The Trump Administration - What to Expect from FDA

    • Policies impacting innovation and product development
    • Incentives to develop new drugs and biologics
    • Policies impacting the supply of drugs and biologics and the downstream impact on the ability of various players to command monopoly pricing

    Learn more about this conference.

  • Wed 23 Nov
  • Wed 2 Nov
    Thu 3 Nov
    3:30-4:30 PMNew York, NY

    Business Workshop  - COMPANY BUILDING - Building the team to grow your company and limit your internal risk– The right Board members and the right management at the right time. Read More...

  • Wed 26 Oct
    11:30am (Full session is 9:00am to 2:00pm, lunch included)Covington & Burling, The New York Times Building, 620 Eighth Avenue, New York, NY 10018-1405

    Moderating Springboard Enterprises' Corporate Dolphin Tank® with panelists Carolyn Green  (Executive Director, Strategic Investments, Pfizer Worldwide R&D) and Kiersten Stead (Monsanto Growth Ventures). Topic is loosely defined to cover insights on what the panelists  look for (specifically and broadly) in the early-stage companies they partner with or invest in. Read More...

  • Mon 17 Oct
    9:00 AM - 12:00 PMStradley Ronon, 2005 Market Street, Suite 2600, Philadelphia, PA

    The Shark Tank style panel will consist of remarks on the healthcare industry and positioning companies to sell in this space. This will be followed by Canadian companies presenting their Value Propositions for feedback, advice, etc. Dr. Gulfo will be joined on the panel by Thompson Boyd (Physician Liaison, Hahnemann Hospital), Michael DellaVeccia (Consultant to the FDA) and Matthew Fetty (Head of Innovation, St. Luke’s Hospital – tentative).

  • Fri 16 Sep
    Sun 18 Sep
    Stanford, California
    The current medical marketplace is vastly different from the marketplace that existed in the 1970s and ’80s when the Food, Drug and Cosmetic Act codified the Food and Drug Administration’s mission. Despite rapidly advancing technology and patients’ increasing desire to try new drugs and devices, the FDA has strayed significantly from the statutorily defined safety and effectiveness standards for drug approvals. Read More...

  • Wed 18 May
    5:30pm - 9:00pmLoeb & Loeb, 345 Park Ave, New York, NY 10154

    MedTech Metro is an intimate forum and networking series designed to showcase New York’s bioscience and medical technology (Bio/Med) community before an audience of investors, business leaders and health care providers committed to promoting and supporting the Bio/Med industry. Learn more about this conference

  • Mon 2 May
    Wed 4 May
    Courtyard by Marriott San Diego Airport, 2592 Laning Rd San Diego, CA 92106

    Veteran device CEO Joseph Gulfo says, “The FDA must be challenged (when appropriate) because it operates in a highly political environment and has strayed from its original mandate.” Read More...

  • Thu 14 Apr
    1:30pm - 7:30pmRise, 43 West 23rd Street, 2nd floor, New York, NY

    Serval Ventures and BodyQuant are convening key leaders from medical research, digital health, pharma, digital security, healthcare, academia, startups and investing for interactive discussions in an invitation only symposium to spur the growth of a healthtech ecosystem in New York. Learn more about this conference

  • Tue 29 Mar
    Thu 31 Mar
    Boston, MA

    Springboard’s Health Innovation Hub is a year-long program for women-led healthcare and life science companies seeking seed and growth funding to fuel expansion and product development. Companies selected for one of the program’s two tracks – Pharma and Health IT/Devices – will be matched with a team of relevant, targeted advisors and participate in several in-person and virtual workshops and presentation sessions throughout the year that provide exposure to influencers, active investors, and potential strategic partners. Learn more about this conference

  • Thu 25 Feb
  • Wed 13 Jan
    8:00 - 9:00amSan Francisco, CA

    FDA 2016: New FDA Commissioner, PDUFA Reauthorization Process, & Biomarkers

    Learn more about this conference

  • Wed 2 Dec
    New York, NY

    The Life Sciences Summit is an early-stage investor and business development conference for emerging companies and academic innovators. The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, and medical research foundations with the goal of advancing new innovations into clinical development. Learn more about this conference


  • Fri 20 Nov
    New Orleans, LA

    FDA Premarket Approval and the Future of Innovation Presentation - "Science and Pre-Market Drug Approvals."

  • Tue 21 Jul
    Thu 23 Jul
    The Carneros Inn (Napa Valley, CA)

    The Biotech CEO Summit is a private meeting for biotech industry leaders where they can talk candidly with other CEOs about the opportunities and challenges facing their organizations and the biotech industry as a whole. The fully-interactive forum uses case studies to launch discussions about the kind of issues only CEOs confront. Learn more about this event.

  • Tue 9 Jun
    Jacob K. Javits Convention Center (New York, NY)

    From Design to Production: Turning a Great Design Concept into a Medical Device Masterpiece.  Event starts at 10am

    Eliminating the Regulatory and Reimbursement Roadblocks to Innovation. Event starts at 3:20pm

    The MD&M East Expo and Conference is the largest, most important and comprehensive medical manufacturing event on the East Coast. It’s the gathering point for more than 500 leading medtech suppliers and manufacturers, including 3M, Abbott, Nypro Healthcare, Phillips-Medisize, and Stratasys. Your pass gives you direct access to them all! Learn more about this conference

  • Tue 12 May
    Wed 13 May
    Washington, DC

    Presenting the Go-To-Market & Dolphin Tank

    An interactive pitch session during which each entrepreneur presents a 2 minute company elevator pitch, then gets feedback from the room. We leverage the collective network and expertise of the people in the room to support to answer one question: “How can we help?” Learn more about this conference


  • Tue 5 May
  • Thu 23 Apr
    Fri 24 Apr
    Boston Convention & Exhibition Center (Boston, MA)

    Picking up the Pieces of Clinical Trial Failure: How I Battled the FDA and Won (Keynote Speaker)

    Failure Forum

    The nature of partnerships in clinical trials is evolving with the increasing influence of game changers like precision medicine and the growing dominance of biologics across multiple therapeutic areas.  Developing these novel drugs using traditional partnering models is no longer feasible and there is a critical need to explore new partnering models and trial designs that are better aligned to the innovation demands of today’s drug development process. Learn more about this conference

  • Wed 8 Apr
    2:30pm - 4:30pmFairleigh Dickinson University School of Pharmacy (Florham Park, NJ)

    FDU's School of Pharmacy welcomes Dr. Joseph V. Gulfo as this year's keynote speaker for the Annual Pieroni Day lecture established in honor of Joseph P. Pieroni, former President and CEO of Japanese pharmaceutical company, Daiichi Sankyo, Inc. Learn more about this event.

  • Mon 2 Mar
    9:30AM - 2:30PMThe Reserve Officer Association Building (Washington, DC)

    Improving the regulatory system is paradoxically one of the most politically contentious areas that the new Congress will address, while offering the greatest possibilities for bipartisan action. Please join the Progressive Policy Institute on March 2, 2015, as our distinguished guests explore prospects for regulatory improvement in the new Congress; examine how regulatory accumulation is holding back entrepreneurship; and discuss how regulators can encourage innovation in health care. Learn more about this conference


  • Mon 12 Jan
    San Francisco, CA

    Workshop - Reading the Tea Leaves - How to Interpret FDA, CMS, and SEC Actions (Moderator)

  • Wed 19 Nov
    6:00pm - 8:00pmSimon Wiesenthal Center Museum of Tolerance, 226 East 42 Street, (Between 2nd and 3rd Avenues) New York, NY, 10017

    Join us for an exciting evening with one of the world’s most illustrious biotech innovators and successful entrepreneurs, Dr. Joseph V. Gulfo, MD, MBA, CEO of Breakthrough Medical Innovations. A winner of the Maverick of The Year Award and an Ernst & Young Entrepreneur of the Year Finalist, Dr. Gulfo has been featured by the Wall Street Journal, Fortune, and Bloomberg TV for his battle to defeat unlawful actions by the FDA. Learn more about this conference

  • Tue 28 Oct
    4:30PM - 5:30PM10 On the Park at Time Warner Center, 60 Columbus Circle, 10th Floor (New York, NY)

    The Life Sciences Summit is an early-stage investor and business development conference for emerging companies and academic innovators. The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, and medical research foundations with the goal of advancing new innovations into clinical development. Learn more about this conference

  • Tue 30 Sep
    1:00pmMotorCity Casino Hotel (Detroit, MI)
    Join us at Michigan's premier bioscience event which draws the largest gathering of bioscience professionals in the state. Learn more about this conference
  • Tue 23 Sep
    8:30-10:00PMUniversity Campus - South Orange, NJ
    Dr. Joseph Gulfo, SHU alum and adjunct professor, will provide a behind-the-scenes look at how inefficiencies at the U.S. Food and Drug Administration (FDA) are slowing down the development of cutting-edge medical innovations.  Read More...

  • Sat 14 Jun
    5:00pmFordham University (Bronx, NY)
    Biopharma & MedTech - The Nexus of Science, Business, and Law

  • Tue 3 Sep
    6:00 - 8:30pmHarvard Club (New York, NY)
    Manhattan Institute’s Young Leaders Circle (YLC) provides New York's young professionals with a distinctive forum to discuss policy ideas, cultural issues, and public affairs.